Topic
Latest reporting and analysis tagged with medical devices.
Alphatec Holdings announced preliminary 2025 financial results on January 12, showing 25% revenue growth and providing a 2026 outlook. The company also entered a strategic agreement with Theradaptive for exclusive U.S. distribution rights to OsteoAdapt.
Eli Lilly, Intuitive Surgical, and Vertex Pharmaceuticals report significant revenue growth driven by weight loss drugs, robotic surgery systems, and cystic fibrosis treatments.
DexCom announced preliminary Q4 2025 revenue of $1.260 billion, up 13% year-over-year, and provided a 2026 revenue forecast of $5.16 billion to $5.25 billion.